American Century Companies’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$334M Sell
636,652
-85,815
-12% -$45.1M 0.18% 80
2025
Q1
$458M Buy
722,467
+14,921
+2% +$9.46M 0.28% 42
2024
Q4
$504M Sell
707,546
-30,949
-4% -$22M 0.29% 36
2024
Q3
$776M Sell
738,495
-87,337
-11% -$91.8M 0.45% 25
2024
Q2
$868M Sell
825,832
-56,073
-6% -$58.9M 0.53% 21
2024
Q1
$849M Sell
881,905
-49,423
-5% -$47.6M 0.53% 21
2023
Q4
$818M Buy
931,328
+14,610
+2% +$12.8M 0.56% 19
2023
Q3
$754M Buy
916,718
+30,050
+3% +$24.7M 0.58% 16
2023
Q2
$637M Sell
886,668
-75,042
-8% -$53.9M 0.48% 24
2023
Q1
$783M Sell
961,710
-140,292
-13% -$114M 0.62% 14
2022
Q4
$795M Sell
1,102,002
-76,069
-6% -$54.9M 0.65% 16
2022
Q3
$812M Buy
1,178,071
+1,345
+0.1% +$927K 0.71% 12
2022
Q2
$696M Buy
1,176,726
+74,420
+7% +$44M 0.57% 18
2022
Q1
$770M Buy
1,102,306
+37,370
+4% +$26.1M 0.53% 23
2021
Q4
$673M Sell
1,064,936
-109,728
-9% -$69.3M 0.43% 39
2021
Q3
$711M Buy
1,174,664
+19,591
+2% +$11.9M 0.49% 34
2021
Q2
$645M Buy
1,155,073
+50,312
+5% +$28.1M 0.44% 38
2021
Q1
$523M Buy
1,104,761
+178,725
+19% +$84.6M 0.38% 52
2020
Q4
$447M Sell
926,036
-3,768
-0.4% -$1.82M 0.35% 61
2020
Q3
$520M Buy
929,804
+31,333
+3% +$17.5M 0.46% 38
2020
Q2
$560M Sell
898,471
-74,292
-8% -$46.3M 0.53% 30
2020
Q1
$475M Sell
972,763
-36,672
-4% -$17.9M 0.57% 29
2019
Q4
$379M Buy
1,009,435
+65,515
+7% +$24.6M 0.36% 67
2019
Q3
$262M Sell
943,920
-88,094
-9% -$24.4M 0.26% 113
2019
Q2
$323M Sell
1,032,014
-9,030
-0.9% -$2.83M 0.32% 81
2019
Q1
$427M Buy
1,041,044
+37,573
+4% +$15.4M 0.43% 49
2018
Q4
$375M Buy
1,003,471
+142,779
+17% +$53.3M 0.43% 48
2018
Q3
$348M Sell
860,692
-51,436
-6% -$20.8M 0.34% 72
2018
Q2
$315M Sell
912,128
-45,061
-5% -$15.5M 0.32% 75
2018
Q1
$330M Buy
957,189
+79,602
+9% +$27.4M 0.33% 76
2017
Q4
$330M Sell
877,587
-39,967
-4% -$15M 0.33% 77
2017
Q3
$410M Buy
917,554
+20,218
+2% +$9.04M 0.42% 52
2017
Q2
$441M Buy
897,336
+49,143
+6% +$24.1M 0.46% 43
2017
Q1
$329M Buy
848,193
+170,695
+25% +$66.1M 0.34% 78
2016
Q4
$249M Buy
677,498
+10,986
+2% +$4.03M 0.27% 116
2016
Q3
$268M Buy
666,512
+64,345
+11% +$25.9M 0.29% 97
2016
Q2
$210M Buy
602,167
+96,340
+19% +$33.6M 0.24% 122
2016
Q1
$182M Buy
505,827
+8,945
+2% +$3.22M 0.21% 133
2015
Q4
$270M Sell
496,882
-19,885
-4% -$10.8M 0.32% 88
2015
Q3
$240M Sell
516,767
-85,122
-14% -$39.6M 0.29% 93
2015
Q2
$307M Sell
601,889
-45,267
-7% -$23.1M 0.35% 73
2015
Q1
$292M Sell
647,156
-90,557
-12% -$40.9M 0.33% 84
2014
Q4
$303M Buy
737,713
+269,815
+58% +$111M 0.34% 75
2014
Q3
$169M Sell
467,898
-133,352
-22% -$48.1M 0.2% 148
2014
Q2
$170M Sell
601,250
-161,350
-21% -$45.6M 0.19% 147
2014
Q1
$229M Sell
762,600
-224,574
-23% -$67.4M 0.27% 105
2013
Q4
$272M Buy
987,174
+164,864
+20% +$45.4M 0.32% 79
2013
Q3
$257M Buy
822,310
+21,686
+3% +$6.78M 0.32% 78
2013
Q2
$180M Buy
+800,624
New +$180M 0.24% 121